Approval · Notice of Compliance 33453 · 2024
MYSTEP: Notice of Compliance 33453
Issued June 13, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33453
- Date
- June 13, 2024
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- PLAN B (Foundation Consumer Healthcare, Llc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYSTEP | 02548461 | Marketed |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB